PMID- 28462079 OWN - NLM STAT- MEDLINE DCOM- 20181115 LR - 20181115 IS - 2212-8778 (Electronic) IS - 2212-8778 (Linking) VI - 6 IP - 5 DP - 2017 May TI - Loss of hepatic DEPTOR alters the metabolic transition to fasting. PG - 447-458 LID - S2212-8778(16)30336-2 [pii] LID - 10.1016/j.molmet.2017.02.005 [doi] AB - OBJECTIVE: The mechanistic target of rapamycin (mTOR) is a serine/threonine kinase that functions into distinct protein complexes (mTORC1 and mTORC2) that regulates growth and metabolism. DEP-domain containing mTOR-interacting protein (DEPTOR) is part of these complexes and is known to reduce their activity. Whether DEPTOR loss affects metabolism and organismal growth in vivo has never been tested. METHODS: We have generated a conditional transgenic mouse allowing the tissue-specific deletion of DEPTOR. This model was crossed with CMV-cre mice or Albumin-cre mice to generate either whole-body or liver-specific DEPTOR knockout (KO) mice. RESULTS: Whole-body DEPTOR KO mice are viable, fertile, normal in size, and do not display any gross physical and metabolic abnormalities. To circumvent possible compensatory mechanisms linked to the early and systemic loss of DEPTOR, we have deleted DEPTOR specifically in the liver, a tissue in which DEPTOR protein is expressed and affected in response to mTOR activation. Liver-specific DEPTOR null mice showed a reduction in circulating glucose upon fasting versus control mice. This effect was not associated with change in hepatic gluconeogenesis potential but was linked to a sustained reduction in circulating glucose during insulin tolerance tests. In addition to the reduction in glycemia, liver-specific DEPTOR KO mice had reduced hepatic glycogen content when fasted. We showed that loss of DEPTOR cell-autonomously increased oxidative metabolism in hepatocytes, an effect associated with increased cytochrome c expression but independent of changes in mitochondrial content or in the expression of genes controlling oxidative metabolism. We found that liver-specific DEPTOR KO mice showed sustained mTORC1 activation upon fasting, and that acute treatment with rapamycin was sufficient to normalize glycemia in these mice. CONCLUSION: We propose a model in which hepatic DEPTOR accelerates the inhibition of mTORC1 during the transition to fasting to adjust metabolism to the nutritional status. FAU - Caron, Alexandre AU - Caron A AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Mouchiroud, Mathilde AU - Mouchiroud M AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Gautier, Nicolas AU - Gautier N AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Labbe, Sebastien M AU - Labbe SM AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Villot, Romain AU - Villot R AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Turcotte, Laurie AU - Turcotte L AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Secco, Blandine AU - Secco B AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Lamoureux, Guillaume AU - Lamoureux G AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Shum, Michael AU - Shum M AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Gelinas, Yves AU - Gelinas Y AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Marette, Andre AU - Marette A AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Richard, Denis AU - Richard D AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. FAU - Sabatini, David M AU - Sabatini DM AD - Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA, 02142, USA; Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA; Koch Center for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, MA, 02139, USA. FAU - Laplante, Mathieu AU - Laplante M AD - Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Faculte de Medecine, Universite Laval, 2725 Chemin Ste-Foy, Quebec, Qc, G1V 4G5, Canada. Electronic address: Mathieu.laplante@criucpq.ulaval.ca. LA - eng GR - R01 AI047389/AI/NIAID NIH HHS/United States GR - R01 CA103866/CA/NCI NIH HHS/United States GR - R37 AI047389/AI/NIAID NIH HHS/United States GR - MOP123387/CIHR/Canada GR - HHMI/Howard Hughes Medical Institute/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20170217 PL - Germany TA - Mol Metab JT - Molecular metabolism JID - 101605730 RN - 0 (Blood Glucose) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (deptor protein, mouse) RN - 9005-79-2 (Glycogen) RN - 9007-43-6 (Cytochromes c) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1) SB - IM MH - Animals MH - Blood Glucose/*metabolism MH - Cytochromes c/metabolism MH - Fasting/*metabolism MH - Glycogen/metabolism MH - Intracellular Signaling Peptides and Proteins/*genetics/metabolism MH - Liver/*metabolism MH - Male MH - Mechanistic Target of Rapamycin Complex 1/metabolism MH - Mice MH - Mice, Inbred C57BL PMC - PMC5404102 OTO - NOTNLM OT - DEPTOR OT - Fasting OT - Glucose OT - Liver OT - mTOR EDAT- 2017/05/04 06:00 MHDA- 2018/11/16 06:00 PMCR- 2017/02/17 CRDT- 2017/05/03 06:00 PHST- 2016/12/15 00:00 [received] PHST- 2017/01/30 00:00 [revised] PHST- 2017/02/13 00:00 [accepted] PHST- 2017/05/03 06:00 [entrez] PHST- 2017/05/04 06:00 [pubmed] PHST- 2018/11/16 06:00 [medline] PHST- 2017/02/17 00:00 [pmc-release] AID - S2212-8778(16)30336-2 [pii] AID - 10.1016/j.molmet.2017.02.005 [doi] PST - epublish SO - Mol Metab. 2017 Feb 17;6(5):447-458. doi: 10.1016/j.molmet.2017.02.005. eCollection 2017 May.